There was a trend towards higher treatment discontinuation rates for genotype 1 than genotype 2/3 patients but this did not reach statistical significance (p=0.16).
← all excerpts
Long-term benefit of hepatitis C therapy in a safety net hospital system: a cross-sectional study with median 5-year follow-up.
1
0.1600
0.1600